Novel Therapeutics

Our research is focused on developing innovative therapeutics that target various forms of kidney disease. This includes genetic diseases such as ADPKD/ARPKD, Alport Syndrome, and GACI, as well as immune-mediated nephritis and conditions like Lupus Nephritis, IgA Nephropathy, and FSGS. Additionally, our pipeline includes treatments for Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD). Our goal is to provide effective and innovative solutions for individuals affected by kidney disease.